We found miR-143 to be upregulated during granulocytic differentiation of primary human CD34+ stem/progenitor cells (HSPCs), primary acute promyelocytic leukemia (APL) patient samples, and various AML cell lines. This evidence concerns the gene CD34 and acute promyelocytic leukemia.